Genesis Molecular AI

Private

Burlingame, CaliforniaHealthcare & Life Scienceshttps://genesis.ml/

Last Round

Convertible Debt

Aug 21, 2023

Total Funding Raised

$280.1M

Company Overview

Genesis Molecular AI is a biotechnology company that has developed a generative and predictive AI platform, GEMS, to accelerate the discovery of small-molecule drugs.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

AI drug discoverysmall molecule drug discoverygenerative AIundruggable targetsdrug discovery platformin silico drug discoverybiotechfoundation modelsphysics-based simulationgenerative biologypharma partnershipsdiffusion modelscomputational chemistrytherapeutics pipelineoncologyimmunology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genesis Molecular AI Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genesis Molecular AI Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Convertible Debt	Aug 21, 2023
Series B	Aug 21, 2023
Series A	Dec 2, 2020
Seed	Nov 21, 2019

View all Funding Rounds

Genesis Molecular AI Investors

Notable investors and investment history

Investor	Rounds
Andreessen Horowitz	Series A, Series B, Seed
Fidelity Management & Research Company	Series B
JAZZ Venture Partners	Series A
Propagator Ventures	Series A
Open Field Capital	Series A
T. Rowe Price	Series B, Series A
Ulu Ventures	Series A

View all Investors

Genesis Molecular AI Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Genesis Molecular AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genesis Molecular AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlingame, California

Year Founded2019

Last FundingAug 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.